🇺🇸 FDA
Patent

US 11850259

Methods of treating viral infections affecting the respiratory tract using topically administered lithium agents

granted A61KA61K31/375A61K31/4706

Quick answer

US patent 11850259 (Methods of treating viral infections affecting the respiratory tract using topically administered lithium agents) held by United States Government as represented by the Department of Veterans Affairs expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/375, A61K31/4706, A61K31/7052, A61K33/00